76181-71-0 ((z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍,Cimetidine)

快速询单

结构式：

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍MOL文件

CAS号：

76181-71-0

中文名称：

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍

英文名称：

Cimetidine

分子式：

C₁₀H₁₆N₆S

分子量：

252.339239120483

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)名称与标识符

名称

中文别名：

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍;

英文别名：

Guanidine, n-cyano-n-methyl-n-[2-[[(5-methyl-1h-imidazol-4-yl)methyl]thio]ethyl]-, (z)-;cimetidine;Tagamet;Eureceptor;Tametin;Dyspamet;Ulcedine;Cimetag;Acinil;Tratul;Ulcedin;Acibilin;Gastromet;Ulcomet;Ulcimet;Edalene;Cimetum;Ulhys;Cimal;Tagamet Hb;Tagamet Hb 200;Cimetidine Hcl;Cimetidina;Ulcomedina;Valmagen;Metracin;Ulcofalk;Ulcestop;Cimetidinum;Gastrobitan;Peptol;Evicer;SKF 92334;Cimetidinum [INN-Latin];Cimetidina [INN-Spanish];2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine;1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)met;

标识符

InChIKey：

AQIXAKUUQRKLND-UHFFFAOYSA-N

Inchi：

1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)

SMILES：

S(CCN/C(=N/C)/NC#N)CC1=C(C)NC=N1

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)物化性质

计算特性

氢键供体数量 : 3
氢键受体数量 : 4
可旋转化学键数量 : 7
重原子数量 : 17
复杂度 : 296
疏水参数计算参考值（XlogP） : 0.4
拓扑分子极性表面积 : 114

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)相关文献

1. On the toxicity and transport mechanisms of cisplatin in kidney tissues in comparison to a gold-based cytotoxic agent
Sarah Spreckelmeyer,Natalia Estrada-Ortiz,Gerian G. H. Prins,Margot van der Zee,Bente Gammelgaard,Stefan Stürup,Inge A. M. de Graaf,Geny M. M. Groothuis,Angela Casini Metallomics 2017 9 1786
2. Optimisation of 1H PMLG homonuclear decoupling at 60 kHz MAS to enable 15N–1H through-bond heteronuclear correlation solid-state NMR spectroscopy
Jacqueline Tognetti,W. Trent Franks,Józef R. Lewandowski,Steven P. Brown Phys. Chem. Chem. Phys. 2022 24 20258
3. Relevance of copper transporter 1 and organic cation transporters 1–3 for oxaliplatin uptake and drug resistance in colorectal cancer cells
I. Bu?,A. Hamacher,N. Sarin,M. U. Kassack,G. V. Kalayda Metallomics 2018 10 414
4. Spectrophotometric determination of cimetidine in tablets with alkaline sodium pentacyanonitrosyliron(III)
Chantana Aromdee,Kamphol Raksrivong,Achara Vathanasanti Analyst 1987 112 1523
5. Determination of pharmaceuticals in freshwater sediments using ultrasonic-assisted extraction with SPE clean-up and HPLC-DAD or LC-ESI-MS/MS detection
Omar S. A. Al-Khazrajy,Alistair B. A. Boxall Anal. Methods 2017 9 4190
6. Pyrazole-based lamellarin O analogues: synthesis, biological evaluation and structure–activity relationships
Karolina Dzedulionyt?,Nina Fuxreiter,Ekaterina Schreiber-Brynzak,Asta ?ukauskait?,Algirdas ?a?kus,Verena Pichler,Egl? Arba?iauskien? RSC Adv. 2023 13 7897
7. Identification of drug transporters involved in the uptake and efflux of rhein in hepatocytes
Yan Dai,Bing-Liang Ma,Min Zheng,Rong Shi,Yuan-Yuan Li,Tian-Ming Wang,Yue-Ming Ma RSC Adv. 2017 7 15236
8. An NMR strategy for obtaining multiple conformational constraints for 15N–13C spin-pair labelled organic solids
Jillian Madine,David A. Middleton Phys. Chem. Chem. Phys. 2006 8 5223
9. Determination of cimetidine in pure form and in dosage forms using N,N-dibromodimethylhydantoin
K. Girish Kumar,L. Karpagaselvi Analyst 1994 119 1375
10. High-throughput wastewater analysis for substance use assessment in central New York during the COVID-19 pandemic
Shiru Wang,Hyatt C. Green,Maxwell L. Wilder,Qian Du,Brittany L. Kmush,Mary B. Collins,David A. Larsen,Teng Zeng Environ. Sci.: Processes Impacts 2020 22 2147

810668-53-2(Methyl (4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxy-4,8, 10,12,14,19-docosahexaenoate) 81115-49-3(6-羧酸-5-氨基-1H-吲唑) 80880-90-6(替仑西平) 812640-83-8((1-(PYRIDIN-2-YL)CYCLOPROPYL)METHANAMINE) 81324-61-0(3-溴-4-甲氧基苯甲酰氯) 80650-47-1(2-chloro-N-(4,5-dihydro-1,3-thiazol-2-yl)acetamide) 809231-57-0(L-2-(BOC-AMINO)-3-(4'-METHOXYBIPHENYL-4-YL)PROPANOIC ACID) 811431-33-1(1-(6-氨基-9H-嘌呤-9-基)-1,5-二脱氧-2,3-O-(1-甲基亚乙基)-BETA-D-呋喃核己糖醛酸)

问答

有谁知道哪些厂家有小包装的N-甲基-N'-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫基]乙基]胍二盐酸盐 59660-24-1？

960化工网为您提供(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.76181-71-0,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:76181-71-0 国际站:76181-71-0

76181-71-0 ((z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍,Cimetidine)

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)名称与标识符

名称

标识符

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)物化性质

计算特性

(z)-n-氰基-n-甲基-n-[2-[[(5-甲基-1H-咪唑-4-基)甲基]硫代]乙基]-胍(76181-71-0)相关文献

目录